Telix Pharmaceuticals is a dynamic, fast-growing radiopharmaceutical company with offices in Australia (HQ), Belgium, Japan, Switzerland, and the United States. Our mission is to deliver on the promise of precision medicine through targeted radiation. At our core, we exist to create products that seek to improve the quality of life for people living with cancer and rare diseases. You will be supporting the international roll-out of our approved prostate cancer imaging agent and helping us to advance our portfolio of late clinical-stage products that address significant unmet need in oncology and rare diseases.

See Yourself at Telix

The Sr Director, Product Development Lead is entrusted with owning and leading the global development of late-stage radiopharmaceutical compounds for therapeutic oncology indications. This role provides cross-functional leadership across clinical, regulatory, CMC, quality, manufacturing/supply chain, and commercial, and drives governance, decision-making, and risk management to deliver program milestones and support regulatory interactions and approvals. This role may include direct people management of one or more Project managers. As a strategic thinker and clear communicator, the role requires a hands-on approach to aligning stakeholders, maintaining an execution-ready integrated plan, and presenting program status, risks, and recommendations to senior leadership.

Key Accountabilities

Development Leadership: Lead the Global Program Leadership Team (GPLT) and hold accountability for cross-functional commitments across CMC, Clinical, and Regulatory. Set and communicate GPLT program objectives in alignment with the Tx BU objective cascade model, ensuring clarity on shared program outcomes vs. functional objectives. Develop and maintain the Global Development Plan (GDP) and Target Product Profile (TPP), ensuring these remain current and drive aligned decision-making across the matrix team.
Strategic Direction: Showcase courage in strategic thinking, guiding matrixed teams through complex decision-making and risk management processes.
Cross-functional Collaboration: Foster a collaborative spirit, working seamlessly with teams spanning clinical, non-clinical, regulatory affairs, quality, manufacturing and supply chain, commercial, medical affairs and program management to formulate plans that achieve program milestones and objectives.
Program Governance & Change Management: Drive integrated cross-functional planning and confirm readiness for key milestones and inflection points; ensure scope, timeline, and budget impacts are assessed and elevated appropriately for leadership review (e.g., Product Management Committee) and that decisions are documented and communicated.
Risk Ownership & Communication: Identify, assign ownership of, and actively manage program risks/issues; communicate risks, mitigations, and decisions clearly to stakeholders and leadership.
Budget Planning & Forecasting: Lead program-level budget planning and forecasting in partnership with Finance and functional leads; monitor spend vs. plan, surface variances, and drive timely re-forecasting and trade-off recommendations to support portfolio decisions.
Regulatory Pathway Design: Partner with Clinical and Regulatory Affairs to craft the ideal development pathway for approval, aiming to meet product attributes and commercial objectives.
Regulatory Interactions & Communication Alignment: Lead cross-functional preparation for key health authority interactions (e.g., FDA Type B), ensuring consistent internal communication, clear objectives, aligned messaging, and timely delivery of high-quality briefing materials and responses.
Executive-Ready Program Reporting: Maintain clear, decision-focused reporting (dashboards, milestone tracking, red/amber/green risks) and ensure critical risks are visible to appropriate leadership teams with recommended actions and owners.
Development Planning: Create and execute comprehensive product development plans and data packages, paving the way for informed go/no-go decisions and continuous progression towards product approval.